.

Deeper Knowledge, Faster

  • Analyze global market entry opportunities
  • Identify first generic entrants
  • Obtain formulation and manufacturing information

► See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

QuintilesIMS
Teva
Farmers Insurance
Chinese Patent Office
Moodys
McKesson
Novartis
Deloitte
Citi
Boehringer Ingelheim

Generated: July 24, 2017

DrugPatentWatch Database Preview

Hydrochlorothiazide; triamterene - Generic Drug Details

« Back to Dashboard

What are the generic sources for hydrochlorothiazide; triamterene and what is the scope of hydrochlorothiazide; triamterene freedom to operate?

Hydrochlorothiazide; triamterene
is the generic ingredient in four branded drugs marketed by Mylan, Lannett Holdings Inc, Sandoz, Am Therap, Pliva, Mylan Pharms Inc, Vitarine, Glaxosmithkline Llc, Watson Labs, Apotex Inc, Duramed Pharms Barr, Novartis, Ivax Sub Teva Pharms, Ani Pharms Inc, and Quantum Pharmics, and is included in twenty-one NDAs. There is one patent protecting this compound. Additional information is available in the individual branded drug profile pages.

There are thirty-one drug master file entries for hydrochlorothiazide; triamterene. Forty suppliers are listed for this compound.

Summary for Generic Name: hydrochlorothiazide; triamterene

Tradenames:4
Patents:1
Applicants:15
NDAs:21
Drug Master File Entries: see list31
Suppliers / Packagers: see list40
Bulk Api Vendors: see list4
Clinical Trials: see list310
Patent Applications: see list33
Drug Prices:see low prices
DailyMed Link:hydrochlorothiazide; triamterene at DailyMed

Pharmacology for Ingredient: hydrochlorothiazide; triamterene

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Ani Pharms Inc
TRIAMTERENE AND HYDROCHLOROTHIAZIDE
hydrochlorothiazide; triamterene
CAPSULE;ORAL074970-001Jan 6, 1998DISCNNoNo► Subscribe► Subscribe► Subscribe
Sandoz
TRIAMTERENE AND HYDROCHLOROTHIAZIDE
hydrochlorothiazide; triamterene
CAPSULE;ORAL074821-001Jun 5, 1997ABRXNoNo► Subscribe► Subscribe► Subscribe
Vitarine
TRIAMTERENE AND HYDROCHLOROTHIAZIDE
hydrochlorothiazide; triamterene
CAPSULE;ORAL071737-001Feb 12, 1988DISCNNoNo► Subscribe► Subscribe► Subscribe
Pliva
TRIAMTERENE AND HYDROCHLOROTHIAZIDE
hydrochlorothiazide; triamterene
TABLET;ORAL074026-001Apr 26, 1996ABRXNoNo► Subscribe► Subscribe► Subscribe
Quantum Pharmics
TRIAMTERENE AND HYDROCHLOROTHIAZIDE
hydrochlorothiazide; triamterene
TABLET;ORAL071980-001Apr 17, 1988DISCNNoNo► Subscribe► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Expired Orange Book Patents for Generic Ingredient: hydrochlorothiazide; triamterene

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Mylan Pharms Inc
MAXZIDE
hydrochlorothiazide; triamterene
TABLET;ORAL019129-001Oct 22, 1984► Subscribe► Subscribe
Mylan Pharms Inc
MAXZIDE-25
hydrochlorothiazide; triamterene
TABLET;ORAL019129-003May 13, 1988► Subscribe► Subscribe
Mylan Pharms Inc
MAXZIDE
hydrochlorothiazide; triamterene
TABLET;ORAL019129-001Oct 22, 1984► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

Harvard Business School
Medtronic
Moodys
Chinese Patent Office
UBS
Express Scripts
Citi
Fuji
Johnson and Johnson
US Army

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted Heap | Mobile and Web Analytics

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot